These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2195673)

  • 1. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
    Khomenko VL; Vasiuk IuA; Romashkin AV; Sivkov SI; Mel'nikov AIu; Buskin VD
    Sov Med; 1990; (3):64-7. PubMed ID: 2195673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
    Korkushko OV; Shatilo VB; Butenko AG
    Sov Med; 1989; (12):66-8. PubMed ID: 2483591
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in using visken in ischemic heart disease and arterial hypertension].
    Komarov FI; Kun IS; Markova VM; Mytareva IL; Ostrovskaia VI
    Sov Med; 1977 Jan; (1):53-5. PubMed ID: 847522
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies on application of Visken in treatment of coronary disease (author's transl)].
    Ziólkowski L; Ilmurzyńska K
    Przegl Lek; 1973; 30(9):771-5. PubMed ID: 4587262
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of visken and cordarone on myocardial function in patients with ischemic heart disease].
    Cherevatov BG; Kucherenko OD; Boiarshin SV
    Sov Med; 1983; (8):65-7. PubMed ID: 6648656
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of treatment with pindolol (Visken) on hemodynamics in patients with primary hypertension].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1986; 29(4):285-91. PubMed ID: 3537436
    [No Abstract]   [Full Text] [Related]  

  • 7. [The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
    Delius L; Lübke KO
    Med Klin; 1974 Jun; 69(25):1117-23. PubMed ID: 4602393
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pindolol in the treatment of arterial hypertension].
    Strozzi C; Cocco G
    Minerva Med; 1978 Jan; 69(4):247-56. PubMed ID: 342988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled study of high blood pressure treatment using betablocker Visken (author's transl)].
    Ripka O; Linhartová J; Jarolím M; Okrouhlík B; Chvatíková J
    Sb Lek; 1975 Oct; 77(10):294-7. PubMed ID: 1101360
    [No Abstract]   [Full Text] [Related]  

  • 11. [A controlled clinical therapeutic trial of prindolol in patients with arterial hypertension (author's transl)].
    Marinković M; Winter-Fudurić ; Kuzmanić D
    Lijec Vjesn; 1976 Apr; 98(4):172-6. PubMed ID: 787710
    [No Abstract]   [Full Text] [Related]  

  • 12. A beta blocker-thiazide combination in the treatment of hypertension in diabetics.
    Chazan BI; Old JM; Venkataraman G; Snape J; Cameron EG
    Br J Clin Pract; 1981; 35(11-12):393-8. PubMed ID: 7030375
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of Visken treatment of severe cases of coronary disease].
    Ilmurzyńska K; Ziólkowski L
    Pol Tyg Lek; 1973 Nov; 28(45):1774-6. PubMed ID: 4765947
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of isoptin on hemodynamics in patients with hypertension and ischemic heart disease].
    Zaslavskaia RM; Budenova LA; Vilkovyskiĭ FA; Malkin LM; Olevskiĭ IKh
    Klin Med (Mosk); 1985 Aug; 63(8):33-6. PubMed ID: 3908807
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of Visken-15 for treating hypertension].
    Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA
    Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of arterial hypertension by pindolol].
    Guédon J; Lucsko M; Chaignon M
    Nouv Presse Med; 1976 Feb; 5(8):511-2. PubMed ID: 817263
    [No Abstract]   [Full Text] [Related]  

  • 18. Experiences in patients treated with Visken.
    Iványi J; Pocsai G
    Ther Hung; 1980; 28(3):109-13. PubMed ID: 7221969
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical use of pindolol (Visken) in the treatment of arterial hypertension].
    Lambić IS; Krstić Lj
    Srp Arh Celok Lek; 1977 Feb; 105(2):191-200. PubMed ID: 905885
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of single-daily-dose pindolol in arterial hypertension].
    Thomas J; Pierredon M; Sankale M
    Therapie; 1978; 33(6):797-804. PubMed ID: 371062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.